HidekiGarrenMD

Physician

Dr. Garren is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Stanford Health Care-Sponsored Stanford UniversityResidency, Neurology, 1994 - 1997
UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Internal Medicine, 1993 - 1994
David Geffen School of Medicine at UCLAClass of 1993

PubMed

9 citations
Myelin water imaging in relapsing multiple sclerosis treated with ocrelizumab and interferon beta-1a.
Shannon Kolind, Shawna Abel, Carolyn Taylor, Roger Tam, Cornelia Laule
Neuroimage. Clinical. 2022-01-01
221 citations
Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
Anthony Traboulsee, Benjamin Greenberg, Jeffrey Bennett, Lech Szczechowski, Edward Fox
The Lancet. Neurology. 2020-05-01
7 citations
Magnetic resonance spectroscopy evidence for declining gliosis in MS patients treated with ocrelizumab versus interferon beta-1a
Erin L. MacMillan, Julia Schubert, Irene M. Vavasour, Roger Tam, Alexander Rauscher
Multiple Sclerosis Journal - Experimental, Translational and Clinical. 2019-10-15

Biotech Company Prothena Taps Walgreens to Recruit Patients for Alzheimer's Drug ResearchApril 13th, 2023
Walgreens and Prothena Partner to Increase Access and Enrollment in Alzheimer’s Disease Clinical TrialApril 13th, 2023
Prothena Corporation Plc (NASDAQ:PRTA) Q4 2022 Earnings Call TranscriptFebruary 28th, 2023
Join now to see all